Although it was discovered that galectin-3 levels were increased locally in the airways of severe COPD patients in the stable cycle and galectin-3 levels were also increased in the blood during exacerbations, its role in COPD patients has not been fully elucidated clinically [13,14]. Here, LGALS3 is linked to chronic obstructive pulmonary disease.